https://www.selleckchem.com/products/gw788388.html
44%, 175/39,895 vs. 1.05%, 1675/159,580, p less then 0.001). After adjustment for age and other variables [adjusted hazard ratio 0.725 (95% confidence interval 0.624-0.803, p less then 0.001)], this study also demonstrated that DXM use appeared to reduce the risk of developing SNHL. This animal study demonstrated that DXM significantly attenuated noise-induced hearing loss. In human study, DXM use may have a protective effect against SNHL.Cancer therapy is still a huge challenge, as especially chemotherapy shows several drawbacks like
Like
Comment
Share
